1. Home
  2. VERA vs NVAX Comparison

VERA vs NVAX Comparison

Compare VERA & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • NVAX
  • Stock Information
  • Founded
  • VERA 2016
  • NVAX 1987
  • Country
  • VERA United States
  • NVAX United States
  • Employees
  • VERA N/A
  • NVAX N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VERA Health Care
  • NVAX Health Care
  • Exchange
  • VERA Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • VERA 2.5B
  • NVAX 2.0B
  • IPO Year
  • VERA 2021
  • NVAX 1995
  • Fundamental
  • Price
  • VERA $42.01
  • NVAX $9.90
  • Analyst Decision
  • VERA Strong Buy
  • NVAX Buy
  • Analyst Count
  • VERA 9
  • NVAX 6
  • Target Price
  • VERA $53.56
  • NVAX $17.83
  • AVG Volume (30 Days)
  • VERA 683.6K
  • NVAX 7.2M
  • Earning Date
  • VERA 11-07-2024
  • NVAX 11-07-2024
  • Dividend Yield
  • VERA N/A
  • NVAX N/A
  • EPS Growth
  • VERA N/A
  • NVAX N/A
  • EPS
  • VERA N/A
  • NVAX N/A
  • Revenue
  • VERA N/A
  • NVAX $987,667,000.00
  • Revenue This Year
  • VERA N/A
  • NVAX N/A
  • Revenue Next Year
  • VERA N/A
  • NVAX N/A
  • P/E Ratio
  • VERA N/A
  • NVAX N/A
  • Revenue Growth
  • VERA N/A
  • NVAX N/A
  • 52 Week Low
  • VERA $9.68
  • NVAX $3.53
  • 52 Week High
  • VERA $50.78
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • VERA 52.57
  • NVAX 36.20
  • Support Level
  • VERA $39.22
  • NVAX $9.52
  • Resistance Level
  • VERA $50.00
  • NVAX $10.63
  • Average True Range (ATR)
  • VERA 2.41
  • NVAX 0.57
  • MACD
  • VERA 0.24
  • NVAX -0.12
  • Stochastic Oscillator
  • VERA 28.53
  • NVAX 9.97

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: